Clinical Evaluation That Connects the Evidence
Bioexcel supports medical device manufacturers with Clinical Evaluation Plans, Clinical Evaluation Reports and complete clinical evidence integration under EU MDR.
Our approach connects literature, state of the art, device-specific clinical data, equivalent-device evidence, PMS, PMCF, Risk Management and benefit-risk conclusions into one structured clinical evaluation.
Does Bioexcel Prepare Clinical Evaluation Reports?
Yes. Bioexcel provides EU MDR clinical evaluation services including CEP and CER development, systematic literature review, state-of-the-art analysis, equivalence assessment, GSPR mapping, PMS/PMCF integration, Risk Management linkage and Notified Body remediation.
Bioexcel Lifesciences & Research LLP is a specialized medical device and IVD clinical research organization providing EU MDR clinical evaluation services including CEP, CER, systematic literature review, state-of-the-art analysis, equivalence assessment, PMS/PMCF integration and clinical evidence remediation.
A CER Should Defend the Clinical Evidence—Not Just Summarize It
A strong clinical evaluation should answer:
- What clinical claims are being made?
- What clinical benefits are expected?
- Which GSPRs require clinical evidence?
- What is the current state of the art?
- What evidence exists for the device?
- What evidence exists from equivalent or similar devices?
- Are the data scientifically valid?
- What residual clinical risks remain?
- What does PMS show?
- What does PMCF show?
- Is the benefit-risk profile acceptable?
- What clinical uncertainties remain?
The CER should make the reasoning behind these conclusions transparent.
From Clinical Questions to Defensible Conclusions
Device & Intended Purpose Review
- Device description
- Indications
- Contraindications
- Target population
- Intended users
- Clinical claims
- Device variants
Output: Clinical Evaluation Scope
Clinical Evidence Questions
- Safety questions
- Performance questions
- Clinical benefit
- Residual risk
- Long-term evidence
- PMCF needs
Output: Clinical Evaluation Questions
Evidence Identification
- Device-specific literature
- Equivalent/similar device literature
- Clinical investigations
- PMS
- PMCF
- Complaints
- Registries
- Real-world evidence
Output: Evidence Inventory
State of the Art
- Current clinical practice
- Alternatives
- Guidelines
- Benchmarks
- Known risks
- Expected clinical outcomes
Output: Clinical Benchmark
Appraisal
- Relevance
- Quality
- Scientific validity
- Applicability
- Bias
- Limitations
Output: Appraised Evidence
Evidence Synthesis
- Safety
- Performance
- Clinical benefit
- Risks
- PMS
- PMCF
Output: Clinical Evidence Conclusions
Benefit-Risk
- Clinical Benefits vs Residual Risks
Output: Benefit-Risk Conclusion
Lifecycle Strategy
- Remaining gaps
- PMCF needs
- PMS implications
- Future updates
Output: Ongoing Clinical Evidence Plan
What Is a Clinical Evaluation Report?
A Clinical Evaluation Report is the documented assessment of clinical data relevant to a medical device. It evaluates whether the available evidence supports the device's safety, performance, clinical benefits and overall benefit-risk profile for the intended purpose.
What clinical evaluation services does Bioexcel provide?
Bioexcel provides CEP, CER, systematic literature review, state-of-the-art analysis, equivalence assessment, GSPR mapping, PMS/PMCF integration, Risk Management linkage and Notified Body remediation.
Can Bioexcel support both writing and evidence generation?
Yes. If CER review identifies a genuine evidence gap, Bioexcel can also support prospective clinical investigation, retrospective PMCF, prospective PMCF or other appropriate evidence-generation activities.
Can Bioexcel support high-risk devices?
Bioexcel supports clinical evaluation programs for complex and higher-risk medical devices, subject to device-specific evidence requirements and project feasibility.
CEP Development
Bioexcel can develop or revise the Clinical Evaluation Plan.
- Device description
- Intended purpose
- Clinical claims
- Scope
- Clinical safety parameters
- Clinical performance parameters
- Clinical benefit parameters
- Relevant GSPRs
- State-of-the-art strategy
- Literature methodology
- Appraisal methodology
- Equivalence strategy
- PMS integration
- PMCF strategy
- Update frequency
Can Bioexcel Prepare a Clinical Evaluation Plan?
Yes. Bioexcel can develop or revise the CEP to define the scope, clinical objectives, evidence requirements, literature methodology, appraisal approach, relevant GSPRs and PMCF strategy before or alongside CER development.
Which GSPRs Require Clinical Evidence?
A recurring weakness in clinical documentation is failure to clearly identify which General Safety and Performance Requirements require support from clinical evidence.
Potential Evidence Sources
Can Bioexcel Map GSPRs to Clinical Evidence?
Yes. Bioexcel can identify clinically relevant GSPRs and build traceability between each requirement, the supporting evidence source and the corresponding CER conclusion.
Literature Search for Clinical Evaluation
Bioexcel can support structured literature searches for:
- Device-specific evidence
- Equivalent-device evidence
- Similar-device evidence
- State of the art
- Alternative treatment options
- Known risks
- Clinical outcomes
Make the Search Reproducible
A structured search protocol may define:
- Objective
- Databases
- Search terms
- Date range
- Language
- Inclusion criteria
- Exclusion criteria
- Screening methodology
- Appraisal methodology
- Update frequency
Show How Literature Was Selected
Where appropriate, Bioexcel can document:
- Records identified
- Duplicates removed
- Records screened
- Records excluded
- Full texts assessed
- Full texts excluded
- Final included articles
The objective is transparent and reproducible evidence selection.
Not Every Published Study Has Equal Evidentiary Value
Bioexcel evaluates literature based on factors such as:
Evidence Output
with justification.
Establish the Clinical Benchmark Before Judging the Device
The State of the Art should define the context within which device safety and performance are evaluated.
- Disease/condition
- Epidemiology
- Current treatment pathway
- Clinical guidelines
- Alternative technologies
- Alternative interventions
- Device categories
- Safety benchmarks
- Performance benchmarks
- Known complications
- Clinical benefit expectations
Can Bioexcel Prepare State-of-the-Art Analysis?
Yes. Bioexcel can develop or strengthen state-of-the-art analysis using current clinical guidelines, treatment alternatives, published evidence and relevant clinical benchmarks.
The Strongest Evidence Is Usually Evidence From the Device Itself
Potential Sources
- Pre-market clinical investigations
- Post-market studies
- PMCF
- Registries
- Published studies
- Real-world clinical data
- Complaint/safety data
Evidence Should Support
- Intended purpose
- Safety
- Performance
- Clinical benefit
- Target population
Connect Clinical Study Results With the CER
Equivalence Under EU MDR Requires More Than Similar Intended Use
Equivalence requires structured comparison across:
Technical Characteristics
- Design
- Specifications
- Properties
- Method of deployment
- Principles of operation
Biological Characteristics
- Patient-contacting materials
- Tissue interaction
- Contact duration
- Surface characteristics
Clinical Characteristics
- Intended purpose
- Clinical condition
- Patient population
- Anatomical site
- User
- Performance
- Clinical outcomes
Can Bioexcel Perform an EU MDR Equivalence Assessment?
Yes. Bioexcel can assess technical, biological and clinical equivalence and determine whether the proposed equivalent-device evidence strategy is sufficiently supported for the intended clinical evaluation.
Equivalence Must Be Evaluated Case by Case
Depending on the device, classification and regulatory strategy, data-access requirements can materially affect whether equivalence can be relied upon. Bioexcel can assess:
- Available equivalent-device documentation
- Public clinical data
- Technical information
- Biological information
- Clinical comparability
- Residual differences
- Regulatory limitations
Similar Devices Can Inform the Clinical Context Without Automatically Establishing Equivalence
Similar-device literature may help support:
- State of the art
- Known complications
- Clinical benchmarks
- Alternatives
- Expected outcomes
The CER should distinguish clearly between equivalent device evidence and similar device / state-of-the-art evidence.
Post-Market Surveillance Must Feed the CER
Bioexcel can integrate:
- Complaints
- Serious incidents
- Trends
- CAPA
- FSCA
- Exposure / sales data
- Literature surveillance
- User feedback
PMCF Should Close Specific Clinical Evidence Gaps
Can Bioexcel Update a CER After PMCF?
Yes. Bioexcel can integrate finalized PMCF evidence into the CER and reassess the impact on safety, performance, clinical benefit, residual risks and benefit-risk conclusions.
CER and Risk Management Should Tell the Same Clinical Story
Bioexcel can assess consistency across:
- Identified hazards
- Clinical harms
- Event frequency
- Residual risks
- Risk controls
- PMCF objectives
- Benefit-risk conclusions
Clinical Benefits Must Be Evaluated Against Residual Risks
Clinical Benefits
- Improved function
- Reduced symptoms
- Improved procedural outcomes
- Reduced hospitalization
- Reduced reintervention
- Improved quality of life
- Improved diagnostic/therapeutic pathway
Compared Against
- Known risks
- Residual risks
- Adverse events
- Device deficiencies
- Long-term uncertainty
One Integrated Clinical Evidence Lifecycle
This cyclical relationship is central to lifecycle clinical evaluation.
Periodic Safety Data Should Remain Consistent With the CER
Where applicable, Bioexcel can review consistency between:
- Sales/exposure
- Complaints
- Serious incidents
- Trends
- PMCF
- Benefit-risk
- CER conclusions
Summary of Safety and Clinical Performance
Where applicable, Bioexcel can support the clinical content and consistency of SSCP sections involving:
- Intended purpose
- Indications
- Contraindications
- Residual risks
- Clinical benefits
- Clinical evaluation summary
- PMCF
- Alternative treatments
Is the Problem the CER—or the Evidence Behind It?
Bioexcel can classify gaps into:
Documentation Gap
Evidence exists but is poorly presented.
Analysis Gap
Evidence exists but has not been adequately analyzed.
Evidence Gap
Required clinical evidence is genuinely missing.
Regulatory Alignment Gap
Clinical documents do not align with GSPR, Risk Management, PMS, PMCF or SSCP.
Can Bioexcel Review a CER Prepared by Another Consultant?
Yes. Bioexcel can independently review an existing CEP or CER, identify clinical, methodological and traceability gaps, and recommend targeted remediation rather than automatically rewriting the entire document.
Strengthen Existing Clinical Evaluation Documentation
Potential remediation scope:
- CER gap assessment
- CEP revision
- Literature search update
- PRISMA update
- SOTA redevelopment
- Equivalence reassessment
- GSPR traceability
- PMS integration
- PMCF integration
- Risk Management consistency
- Benefit-risk revision
Received a CER Nonconformity?
Common issues may include:
- Insufficient clinical evidence
- Weak literature methodology
- Outdated state of the art
- Unsupported equivalence
- Insufficient device-specific evidence
- Missing GSPR traceability
- Generic PMCF
- PMS not integrated
- Benefit-risk not adequately justified
- Risk Management inconsistencies
Can Bioexcel Help With a Notified Body CER Finding?
Yes. Bioexcel can interpret the finding, identify the underlying clinical evidence or documentation gap, strengthen the CER and related evidence package, and support additional clinical evidence generation when required.
Some CER Problems Cannot Be Solved With More Writing
If the underlying issue is insufficient clinical evidence, potential options may include:
Clinical Evaluation for Complex & Implantable Devices
Bioexcel can support CER programs for complex technologies including:
Often Require Particularly Strong
- Device-specific evidence
- Long-term evidence
- PMCF
- Risk linkage
- Benefit-risk justification
Clinical Evaluation Is a Lifecycle Process
CER updates may be triggered by:
How Often Should a CER Be Updated?
The appropriate update frequency depends on device risk, regulatory requirements, post-market findings, PMCF activity, new clinical evidence and changes to the device or state of the art. The CER should be maintained as part of the ongoing clinical evaluation process rather than treated as a one-time document.
Every Major Clinical Conclusion Should Be Traceable
This helps regulators understand how evidence supports the manufacturer's claims.
Clinical Evaluation Medical Writing
Bioexcel can support:
- CEP
- CER
- Literature Search Protocol
- Literature Search Report
- SOTA
- Equivalence Assessment
- Evidence tables
- PMCF integration
- Regulatory responses
Connected Clinical Evidence Services
Clinical evaluation draws on evidence and analysis generated across these related services.
Why Manufacturers Use Bioexcel for Clinical Evaluation
Medical Device Focus
CERs are developed around device-specific clinical evidence requirements.
Clinical Operations Insight
Bioexcel understands how the underlying studies and PMCF are generated.
Literature + Clinical Data Integration
Published evidence and real-world/device-specific data are evaluated together.
PMS + PMCF Integration
Clinical evaluation remains connected to lifecycle evidence.
Risk Management Alignment
Clinical harms and benefit-risk are cross-checked with Risk Management.
Remediation Capability
Bioexcel can move from document remediation into new evidence generation if required.
EU MDR CER Nonconformity Resolution – Urology Portfolio
A medical device manufacturer received Notified Body findings across several CERs.
Key Gaps
- Literature evidence required strengthening
- Equivalence justification required improvement
- State-of-the-art alignment required revision
- PMS and Risk Management linkage needed strengthening
- Benefit-risk conclusions required additional support
Bioexcel's Approach
- Finding-by-finding gap assessment
- Literature review strengthening
- Traceability improvement
- Equivalence reassessment
- SOTA update
- PMS integration
- Risk Management linkage
- Benefit-risk revision
Outcome: The affected CERs and supporting clinical evidence package were updated for regulatory resubmission.
Frequently Asked Questions About Clinical Evaluation
Clinical evaluation is the systematic and planned process of continuously generating, collecting, analyzing and assessing clinical data relevant to a medical device in order to verify its safety, performance and clinical benefit for the intended purpose.
Bioexcel builds the clinical argument behind the CER—not just the document itself.